Table 3 Pharmaceutical issues related to effectiveness of therapy and action taken to resolve them
| Pharmaceutical care issues | n (%) | Recommendations to clinician and action taken by clinician to resolve it (italicized) |
|---|---|---|
| Effectiveness of therapy (B) | ||
| Patients whose blood pressure levels were above or equal to 160/100 | 15(20) |
Dosage adjustments and/or add on therapy. a Changed dosage of antihypertensive (n = 9) a Added an additional antihypertensive (n = 5) |
| Aspirin prescribed when BP was not controlled. | 5(6.67) |
Aspirin be discontinued. a Aspirin discontinued(n = 3) |
| Atenolol and carvedilol prescribed as monotherapy for the management of hypertension. | 2(2.60) |
Beta blocker be changed to calcium channel blocker or a diuretic a Beta blocker changed to a diuretic (n = 2) |
| Furosemide prescribed for the management of hypertension | 1(1.33) |
Furosemide to be changed to bendrofluazide a Furosemide substituted with bendrofluazide |